Vairākkārt forumā runāts par malārijas profilaksi, tagad jaunumi Denges jeb tropu drudža profilaksei, Sanofi vakcīna akceptēta Filipīnās: http://www.thebitbag.com/first-ever-dengue-vaccine-is-now-in-the-philippines/132542

Clinical tests that were carried out in a total of 40,000 people from 15 countries concluded that Dengvaxia can immunize two-thirds of people aged nine years and above, rising to 93 percent for the more severe form of the disease, dengue haemorrhagic fever. It was also said to reduce the risk of hospitalization by 80 percent.

Over more than a million doses of the vaccine are ready to ship anytime, and Sanofi expects an annual production of more than 100 million doses by 2017. Sanofi’s research and development took almost 20 years, costing more than 1.5 billion euros.

Pieļauju, ka ja reiz efektivitāte ir ap 90 procentiem, gan arī pie mums drīz būs pieejama vakcinācijas kabinetos, kā tikko piereģistrēs Eiropā (varbūt jau ir? nepārbaudīju). Tad jāgaida, kad būs pret zikas vīrusu, cerams, ātrāk nekā pēc 20 gadiem.